Absci reports second quarter 2022 financial results and busi

Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic

Related Keywords

Sean Mcclain , Absci Corporation Nasdaq , Absci Corporation , Active Programs , Machine Learning Workshop , Computational Biology , Denise Dettore , Chief People Officer , Jack Gold , Chief Marketing ,